Ticker: CRL

Charles River Laboratories International, Inc. (NYSE: CRL) has recently reported its financial results for the quarterly period ended June 28, 2025. The company operates in the global drug development sector, providing essential services to pharmaceutical and biotechnology companies. Key Highligh...

Charles River Laboratories International, Inc. (NYSE: CRL) - Q1 2025 Earnings Overview During the first quarter ended March 29, 2025, Charles River Laboratories reported a decline in revenue and net income compared to the same period in 2024, marking significant operational challenges amid ongoin...